Indaptus Therapeutics Inc (INDP)
2.39
-0.01
(-0.42%)
USD |
NASDAQ |
May 17, 16:00
2.39
0.00 (0.00%)
Pre-Market: 20:00
Indaptus Therapeutics 1 Year Total Returns (Daily): 12.68% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 12.68% |
| May 16, 2024 | 15.94% |
| May 15, 2024 | 9.13% |
| May 14, 2024 | 0.95% |
| May 13, 2024 | 0.47% |
| May 10, 2024 | 0.00% |
| May 09, 2024 | 3.22% |
| May 08, 2024 | -14.11% |
| May 07, 2024 | -17.01% |
| May 06, 2024 | -17.82% |
| May 03, 2024 | -22.61% |
| May 02, 2024 | -22.22% |
| May 01, 2024 | -19.91% |
| April 30, 2024 | -16.83% |
| April 29, 2024 | -18.67% |
| April 26, 2024 | -17.90% |
| April 25, 2024 | -17.11% |
| April 24, 2024 | -9.97% |
| April 23, 2024 | -12.94% |
| April 22, 2024 | -14.69% |
| April 19, 2024 | -22.37% |
| April 18, 2024 | 2.10% |
| April 17, 2024 | 33.67% |
| April 16, 2024 | 43.07% |
| April 15, 2024 | 34.23% |
| Date | Value |
|---|---|
| April 12, 2024 | 53.04% |
| April 11, 2024 | 52.78% |
| April 10, 2024 | 40.38% |
| April 09, 2024 | 42.20% |
| April 08, 2024 | 37.86% |
| April 05, 2024 | 37.56% |
| April 04, 2024 | 24.31% |
| April 03, 2024 | 21.62% |
| April 02, 2024 | 26.49% |
| April 01, 2024 | 24.32% |
| March 28, 2024 | 27.27% |
| March 27, 2024 | 37.19% |
| March 26, 2024 | 47.36% |
| March 25, 2024 | 30.53% |
| March 22, 2024 | 38.92% |
| March 21, 2024 | 40.12% |
| March 20, 2024 | 38.10% |
| March 19, 2024 | 26.54% |
| March 18, 2024 | 19.14% |
| March 15, 2024 | 23.03% |
| March 14, 2024 | 21.66% |
| March 13, 2024 | 19.05% |
| March 12, 2024 | 22.54% |
| March 11, 2024 | 19.58% |
| March 08, 2024 | 30.30% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.65%
Minimum
Dec 27 2022
53.04%
Maximum
Apr 12 2024
-24.29%
Average
-21.72%
Median
1 Year Total Returns (Daily) Benchmarks
| Quoin Pharmaceuticals Ltd | -86.69% |
| CEL-SCI Corp | -52.96% |
| AIM ImmunoTech Inc | -19.40% |
| IGC Pharma Inc | 69.70% |
| NovaBay Pharmaceuticals Inc | -83.53% |